FDA publishes a draft guidance explaining its view of Congress requirement that it apply least burdensome principles to medical device review.
FDA scientists say it is possible to standardize high throughput sequencing to screen biologics for contamination.
Federal Register notice: FDA seeks comments on an information collection extension for Prescription Drug Marketing Act of 1987 Administrative Procedu...
Federal Register notice: FDA seeks comments on an information collection extension for Current Good Manufacturing Practice Regulations for Finished Ph...
Federal Register notice: FDA announces a 3/19/18 public workshop entitled Patient-Focused Drug Development: Developing and Submitting Proposed Draft G...
The Federal Circuit Court of Appeals rules against Amgen in the continuing dispute between it and Sandoz over application of provisions of the Biologi...
An updated FDA assessment says the agency continues to caution against using laparoscopic power morcellators to treat presumed uterine fibroids.
FDA releases the FDA-483 issued after a 2014 inspection at Baxter Healthcare.